US Patent 8263083 Combination therapy with antibody-drug conjugates
Patent 8263083 was granted and assigned to Seagen on September, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 8, 2008
Date of Patent
September 11, 2012
Patent Application Number
12681599
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8263083 Combination therapy with antibody-drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.